1. Home
  2. PJT vs AAPG Comparison

PJT vs AAPG Comparison

Compare PJT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PJT
  • AAPG
  • Stock Information
  • Founded
  • PJT 2014
  • AAPG 2009
  • Country
  • PJT United States
  • AAPG China
  • Employees
  • PJT N/A
  • AAPG N/A
  • Industry
  • PJT Investment Managers
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PJT Finance
  • AAPG Health Care
  • Exchange
  • PJT Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • PJT 4.5B
  • AAPG 4.0B
  • IPO Year
  • PJT N/A
  • AAPG 2025
  • Fundamental
  • Price
  • PJT $179.29
  • AAPG $41.98
  • Analyst Decision
  • PJT Hold
  • AAPG Buy
  • Analyst Count
  • PJT 3
  • AAPG 1
  • Target Price
  • PJT $187.00
  • AAPG N/A
  • AVG Volume (30 Days)
  • PJT 189.8K
  • AAPG 9.5K
  • Earning Date
  • PJT 10-28-2025
  • AAPG 08-20-2025
  • Dividend Yield
  • PJT 0.56%
  • AAPG N/A
  • EPS Growth
  • PJT 54.67
  • AAPG N/A
  • EPS
  • PJT 5.83
  • AAPG N/A
  • Revenue
  • PJT $1,537,018,000.00
  • AAPG $54,524,554.00
  • Revenue This Year
  • PJT $12.16
  • AAPG N/A
  • Revenue Next Year
  • PJT $12.52
  • AAPG $387.72
  • P/E Ratio
  • PJT $30.73
  • AAPG N/A
  • Revenue Growth
  • PJT 18.48
  • AAPG N/A
  • 52 Week Low
  • PJT $116.07
  • AAPG $16.50
  • 52 Week High
  • PJT $190.28
  • AAPG $48.45
  • Technical
  • Relative Strength Index (RSI)
  • PJT 54.74
  • AAPG N/A
  • Support Level
  • PJT $177.33
  • AAPG N/A
  • Resistance Level
  • PJT $186.44
  • AAPG N/A
  • Average True Range (ATR)
  • PJT 4.06
  • AAPG 0.00
  • MACD
  • PJT -0.20
  • AAPG 0.00
  • Stochastic Oscillator
  • PJT 65.50
  • AAPG 0.00

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: